Nexposed (%) | Nunexposed (%) | OR | 95% CI | |
---|---|---|---|---|
Routine surveillance | ||||
Income level groups | ||||
Low | 6 (43) | 8 (57) | Ref. | - |
Lower middle | 25 (74) | 9 (26) | 3.7 | (1.0–14) |
Upper middle | 30 (91) | 3 (9) | 13 | (3.0–77) |
High | 38 (100) | 0 (0) | ∞ | ∞ |
Human Development Index groups | ||||
Low | 8 (38) | 13 (62) | Ref. | - |
Lower middle | 22 (79) | 6 (21) | 6.0 | (1.8–23) |
Upper middle | 32 (97) | 1 (3) | 52 | (8.5–1020) |
High | 37 (100) | 0 (0) | ∞ | ∞ |
Health expenditure groups | ||||
Low | 12 (48) | 13 (52) | Ref. | - |
Lower middle | 25 (83) | 5 (17) | 5.4 | (1.7–20) |
Upper middle | 26 (93) | 2 (7) | 14 | (3.3–100) |
High | 36 (100) | 0 (0) | ∞ | ∞ |
Physician density groups | ||||
Low | 7 (37) | 12 (63) | Ref. | - |
Lower middle | 24 (86) | 4 (14) | 10 | (2.7–47) |
Upper middle | 30 (88) | 4 (12) | 13 | (3.4–59) |
High | 38 (100) | 0 (0) | ∞ | ∞ |
Prevention in healthcare settings | ||||
Income level groups | ||||
Low | 5 (36) | 9 (64) | Ref. | - |
Lower middle | 17 (50) | 17 (50) | 1.8 | (0.5–7.0) |
Upper middle | 29 (88) | 4 (12) | 13 | (3.1–67) |
High | 33 (87) | 5 (13) | 12 | (3.0–55) |
Human Development Index groups | ||||
Low | 8 (38) | 13 (62) | Ref. | - |
Lower middle | 22 (79) | 6 (21) | 3.1 | (0.9–11) |
Upper middle | 32 (97) | 1 (3) | 7.4 | (2.3–27) |
High | 37 (100) | 0 (0) | 23 | (5.7–120) |
Health expenditure groups | ||||
Low | 7 (28) | 18 (72) | Ref. | - |
Lower middle | 22 (73) | 8 (27) | 7.0 | (2.3–25) |
Upper middle | 24 (86) | 4 (14) | 15 | (4.3–69) |
High | 31 (86) | 5 (14) | 16 | (4.7–64) |
Physician density groups | ||||
Low | 5 (26) | 14 (74) | Ref. | - |
Lower middle | 19 (68) | 9 (32) | 5.9 | (1.7–23) |
Upper middle | 28 (82) | 6 (18) | 13 | (3.6–56) |
High | 32 (84) | 6 (16) | 15 | (4.2–63) |